Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)

II. Biomarker studies

Henry T. Lynch, G. S. Schuelke, W. J. Kimberling, W. A. Albano, K. A. Biscone, M. L. Lipkin, E. E. Deschner, Y. B. Mikol, A. A. Sandberg

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Nine families with the cancer family syndrome (CFS), or Lynch syndrome II, and two with hereditary site-specific colonic cancer (HSSCC), or Lynch syndrome I, were investigated for the following potential biomarkers of genotype status: (1) in vitro tetraploidy of dermal fibroblast monolayer cultures; (2) tritiated thymidine uptake (3HdThd) labeling of colonic mucosa; (3) cytogenetics of peripheral blood mononuclear leukocytes; (4) quantitative serum immunoglobulin determinations; (5) methionine dependence in dermal fibroblasts in tissue culture; (6) segregation analysis; and (7) the study of gene linkage with respect to 25 landmark serum and blood group markers. Positive lod scores of 3.19 for linkage of the Jk (Kidd blood group) with CFS were obtained. Both in vitro tetraploidy and 3HdThd uptake in the distal colonic muscosal crypt compartments were positively associated with cancer risk status in CFS and HSSCC kindreds. There was a high incidence of polymorphisms of centromeric heterochromatin, including complete inversion. These findings are of particular clinical and genetic significance because HNPCC lacks premonitory signs of cancer risk. If confirmed, they could conceivably enable definition of genotype as early as birth in members of HNPCC kindreds, thereby enabling psychologic preparation and intensive cancer education for improved compliance in surveillance/management programs. These studies also provide new clues about the chromosome(s) bearing the presumed cancer gene(s). For example, CFS gene(s) may possibly be located on chromosome 2, where Jk is located. These biomarkers merit intensive study in additional HNPCC kindreds for a more complete assessment of their sensitivity and specificity. Additionally, essential aspects of previous reports involving biologic samples from these and/or similar subject kindreds are included to permit a comprehensive presentation of the combined findings of this consortium to date.

Original languageEnglish
Pages (from-to)939-951
Number of pages13
JournalCancer
Volume56
Issue number4
DOIs
StatePublished - 1985

Fingerprint

Lynch Syndrome II
Hereditary Nonpolyposis Colorectal Neoplasms
Biomarkers
Neoplasms
Tetraploidy
Blood Group Antigens
Fibroblasts
Hereditary Neoplastic Syndromes
Genotype
Lod Score
Mononuclear Leukocytes
Skin
Chromosomes, Human, Pair 2
Heterochromatin
Neoplasm Genes
Serum
Cytogenetics
Methionine
Colonic Neoplasms
Thymidine

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Lynch, H. T., Schuelke, G. S., Kimberling, W. J., Albano, W. A., Biscone, K. A., Lipkin, M. L., ... Sandberg, A. A. (1985). Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): II. Biomarker studies. Cancer, 56(4), 939-951. https://doi.org/10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T

Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II) : II. Biomarker studies. / Lynch, Henry T.; Schuelke, G. S.; Kimberling, W. J.; Albano, W. A.; Biscone, K. A.; Lipkin, M. L.; Deschner, E. E.; Mikol, Y. B.; Sandberg, A. A.

In: Cancer, Vol. 56, No. 4, 1985, p. 939-951.

Research output: Contribution to journalArticle

Lynch, HT, Schuelke, GS, Kimberling, WJ, Albano, WA, Biscone, KA, Lipkin, ML, Deschner, EE, Mikol, YB & Sandberg, AA 1985, 'Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): II. Biomarker studies', Cancer, vol. 56, no. 4, pp. 939-951. https://doi.org/10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T
Lynch, Henry T. ; Schuelke, G. S. ; Kimberling, W. J. ; Albano, W. A. ; Biscone, K. A. ; Lipkin, M. L. ; Deschner, E. E. ; Mikol, Y. B. ; Sandberg, A. A. / Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II) : II. Biomarker studies. In: Cancer. 1985 ; Vol. 56, No. 4. pp. 939-951.
@article{e89ce73fd1024e47ae11cc6da095dbcf,
title = "Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): II. Biomarker studies",
abstract = "Nine families with the cancer family syndrome (CFS), or Lynch syndrome II, and two with hereditary site-specific colonic cancer (HSSCC), or Lynch syndrome I, were investigated for the following potential biomarkers of genotype status: (1) in vitro tetraploidy of dermal fibroblast monolayer cultures; (2) tritiated thymidine uptake (3HdThd) labeling of colonic mucosa; (3) cytogenetics of peripheral blood mononuclear leukocytes; (4) quantitative serum immunoglobulin determinations; (5) methionine dependence in dermal fibroblasts in tissue culture; (6) segregation analysis; and (7) the study of gene linkage with respect to 25 landmark serum and blood group markers. Positive lod scores of 3.19 for linkage of the Jk (Kidd blood group) with CFS were obtained. Both in vitro tetraploidy and 3HdThd uptake in the distal colonic muscosal crypt compartments were positively associated with cancer risk status in CFS and HSSCC kindreds. There was a high incidence of polymorphisms of centromeric heterochromatin, including complete inversion. These findings are of particular clinical and genetic significance because HNPCC lacks premonitory signs of cancer risk. If confirmed, they could conceivably enable definition of genotype as early as birth in members of HNPCC kindreds, thereby enabling psychologic preparation and intensive cancer education for improved compliance in surveillance/management programs. These studies also provide new clues about the chromosome(s) bearing the presumed cancer gene(s). For example, CFS gene(s) may possibly be located on chromosome 2, where Jk is located. These biomarkers merit intensive study in additional HNPCC kindreds for a more complete assessment of their sensitivity and specificity. Additionally, essential aspects of previous reports involving biologic samples from these and/or similar subject kindreds are included to permit a comprehensive presentation of the combined findings of this consortium to date.",
author = "Lynch, {Henry T.} and Schuelke, {G. S.} and Kimberling, {W. J.} and Albano, {W. A.} and Biscone, {K. A.} and Lipkin, {M. L.} and Deschner, {E. E.} and Mikol, {Y. B.} and Sandberg, {A. A.}",
year = "1985",
doi = "10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T",
language = "English",
volume = "56",
pages = "939--951",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)

T2 - II. Biomarker studies

AU - Lynch, Henry T.

AU - Schuelke, G. S.

AU - Kimberling, W. J.

AU - Albano, W. A.

AU - Biscone, K. A.

AU - Lipkin, M. L.

AU - Deschner, E. E.

AU - Mikol, Y. B.

AU - Sandberg, A. A.

PY - 1985

Y1 - 1985

N2 - Nine families with the cancer family syndrome (CFS), or Lynch syndrome II, and two with hereditary site-specific colonic cancer (HSSCC), or Lynch syndrome I, were investigated for the following potential biomarkers of genotype status: (1) in vitro tetraploidy of dermal fibroblast monolayer cultures; (2) tritiated thymidine uptake (3HdThd) labeling of colonic mucosa; (3) cytogenetics of peripheral blood mononuclear leukocytes; (4) quantitative serum immunoglobulin determinations; (5) methionine dependence in dermal fibroblasts in tissue culture; (6) segregation analysis; and (7) the study of gene linkage with respect to 25 landmark serum and blood group markers. Positive lod scores of 3.19 for linkage of the Jk (Kidd blood group) with CFS were obtained. Both in vitro tetraploidy and 3HdThd uptake in the distal colonic muscosal crypt compartments were positively associated with cancer risk status in CFS and HSSCC kindreds. There was a high incidence of polymorphisms of centromeric heterochromatin, including complete inversion. These findings are of particular clinical and genetic significance because HNPCC lacks premonitory signs of cancer risk. If confirmed, they could conceivably enable definition of genotype as early as birth in members of HNPCC kindreds, thereby enabling psychologic preparation and intensive cancer education for improved compliance in surveillance/management programs. These studies also provide new clues about the chromosome(s) bearing the presumed cancer gene(s). For example, CFS gene(s) may possibly be located on chromosome 2, where Jk is located. These biomarkers merit intensive study in additional HNPCC kindreds for a more complete assessment of their sensitivity and specificity. Additionally, essential aspects of previous reports involving biologic samples from these and/or similar subject kindreds are included to permit a comprehensive presentation of the combined findings of this consortium to date.

AB - Nine families with the cancer family syndrome (CFS), or Lynch syndrome II, and two with hereditary site-specific colonic cancer (HSSCC), or Lynch syndrome I, were investigated for the following potential biomarkers of genotype status: (1) in vitro tetraploidy of dermal fibroblast monolayer cultures; (2) tritiated thymidine uptake (3HdThd) labeling of colonic mucosa; (3) cytogenetics of peripheral blood mononuclear leukocytes; (4) quantitative serum immunoglobulin determinations; (5) methionine dependence in dermal fibroblasts in tissue culture; (6) segregation analysis; and (7) the study of gene linkage with respect to 25 landmark serum and blood group markers. Positive lod scores of 3.19 for linkage of the Jk (Kidd blood group) with CFS were obtained. Both in vitro tetraploidy and 3HdThd uptake in the distal colonic muscosal crypt compartments were positively associated with cancer risk status in CFS and HSSCC kindreds. There was a high incidence of polymorphisms of centromeric heterochromatin, including complete inversion. These findings are of particular clinical and genetic significance because HNPCC lacks premonitory signs of cancer risk. If confirmed, they could conceivably enable definition of genotype as early as birth in members of HNPCC kindreds, thereby enabling psychologic preparation and intensive cancer education for improved compliance in surveillance/management programs. These studies also provide new clues about the chromosome(s) bearing the presumed cancer gene(s). For example, CFS gene(s) may possibly be located on chromosome 2, where Jk is located. These biomarkers merit intensive study in additional HNPCC kindreds for a more complete assessment of their sensitivity and specificity. Additionally, essential aspects of previous reports involving biologic samples from these and/or similar subject kindreds are included to permit a comprehensive presentation of the combined findings of this consortium to date.

UR - http://www.scopus.com/inward/record.url?scp=0022000759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022000759&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T

DO - 10.1002/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T

M3 - Article

VL - 56

SP - 939

EP - 951

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -